Basic and Clinical Immunology – 3030. Subcutaneous Immunoglobulin Therapy: An Option for Patients Who Have Experienced Thrombotic Complications With Intravenous Therapy

World Allergy Organization Journal - United Kingdom
doi 10.1186/1939-4551-6-s1-p205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intravenous Immunoglobulin as Clinical Immune-Modulating Therapy

CMAJ
Medicine
2015English

Treatment Costs Associated With Hospital-Based Intravenous Immunoglobulin Therapy Compared to Home-Based Subcutaneous Immunoglobulin Therapy in a Cohort of Paediatric Patients With Primary Immunodeficiency

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2011English

A Study of Patients With Kawasaki Disease Who Required an Additional Immunoglobulin Therapy

Pediatric Research
Child HealthPediatricsPerinatology
2003English

High-Dose Intravenous Immunoglobulin Therapy for Eosinophilic Granulomatosis With Polyangiitis

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Intravenous Immunoglobulin Therapy for Resistant Ocular Behcet's Disease

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Corticosteroid-Sparing Effect of Intravenous Immunoglobulin Therapy in Patients With Pemphigus Vulgaris

Archives of Dermatology
2002English

Prevention of Peripheral Venous Catheter Complications With an Intravenous Therapy Team

Archives of Internal Medicine
1998English

Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients With COVID-19: A Multicenter Retrospective Cohort Study

2020English

Preference for Subcutaneous Injection or Intravenous Infusion of Biological Therapy Among Italian Patients With SLE

Journal of Patient Experience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy